HDL Is Not Always Good Cholesterol During Menopause Transition
Data from the large-scale SWAN study suggest a rethinking of HDL as beneficial cholesterol for women in menopause.
Data from the large-scale SWAN study suggest a rethinking of HDL as beneficial cholesterol for women in menopause.
Recommendations from the American College of Cardiology/American Heart Association Task Force on the management of blood cholesterol.
Dennis R. Leahy, MD, shares his POV on the value of making Lp(a) testing universal, not only to inform patients and their clinicians of the high CV risks, but to make way for potential treatments.
Author describes efficacy and safety information on red yeast rice in the treatment of dyslipidemia.
The risk for recurrent MACE was high among survivors of a first ever acute coronary syndrome with a substantial number of these being fatal; 34.4% had MACE within 1 year and 48.4% in 3 years.
Lifestyle behavior treatment should be the first-line treatment for patients with mildly elevated blood pressure and cholesterol.
Obesity, elevated blood pressure prevalent in younger Black women, even those in their 20s and 30s
A new study confirms that the timing of meals affects cardiometabolic risk factors and the ability to lose weight.
Cross-sex hormone therapy may have a negative effect on lipid profile and glucose levels in transgender men but not in transgender women.
The blood levels of non-high density lipoprotein cholesterol were found to have a strong association with the long-term risk for a cardiovascular disease event.